Oral dosage forms of gemcitabine derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7068 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2600399

The present invention relates to oral dosage forms of certain long chain saturated and monounsaturated fatty acid derivatives of 2',2'- difluorodeoxycytidine (Gemcitabine). In particular, the present invention relates to the use of the said gemcitabine derivatives or a pharmaceutical acceptable salt thereof for preparing an oral dosage form ameliorating compliance in treatment of cancer.

L'invention concerne des formes de dosage oral de certains dérivés d'acides gras saturés et mono-insaturés à chaîne longue de 2',2'-difluorodéoxycytidine (Gemcitabine). L'invention concerne, en particulier, l'utilisation de dérivés de gemcitabine ou d'un sel pharmaceutiquement acceptable de ceux-ci pour préparer une forme de dosage oral permettant d'améliorer l'adhésion au traitement d'un cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral dosage forms of gemcitabine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral dosage forms of gemcitabine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral dosage forms of gemcitabine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1574881

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.